FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on protocol VP-VLY-686-3403, which until today limited the protocol to a maximum of 90 doses of tradipitant. https://mma.prnewswire.com/media/2090054/VandaLogo_v1.jpg The lift followed Vanda's formal dispute resolution request and an expedited re-review conducted by CDER leadership […]

Contact Levi & Korsinsky by January 16, 2026 Deadline to Join Class Action Against Perrigo Company plc(PRGO)

(NYSE:PRGO), NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Perrigo Company plc (“Perrigo Company plc” or the “Company”) (NYSE: PRGO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Perrigo Company plc investors who were adversely affected by alleged securities

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. Lawsuit – TLX

(NASDAQ:TLX), NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. (“Telix Pharmaceuticals Ltd.” or the “Company”) (NASDAQ: TLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix Pharmaceuticals Ltd. investors who were adversely affected by alleged securities

Contact Levi & Korsinsky by January 16, 2026 Deadline to Join Class Action Against Perrigo Company plc(PRGO)

Contact Levi & Korsinsky by January 16, 2026 Deadline to Join Class Action Against Perrigo Company plc(PRGO) GlobeNewswire December 04, 2025 NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Perrigo Company plc (“Perrigo Company plc” or the “Company”) (NYSE: PRGO) of a class action securities lawsuit. CLASS DEFINITION:

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. Lawsuit – TLX

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. Lawsuit – TLX GlobeNewswire December 04, 2025 NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. (“Telix Pharmaceuticals Ltd.” or the “Company”) (NASDAQ: TLX) of a class action

Best CD Rates in December 2025: CD Valet Analysis Highlights Top Yields Amid Decline

CD Valetis a digital marketplace that connects consumers with the best CD rates and terms nationwide, helping community financial institutions effectively attract new deposits. The company today reported that as of November 30, 2025, many 12-month CDs are still offering rates around or above 4.00% APY-despite a broader trend of declining yields. These remain some

STAG INDUSTRIAL TO PARTICIPATE IN NAREIT CONFERENCE

STAG Industrial, Inc. (the “Company”) (NYSE: STAG) announced today that it will be participating in NAREIT's REITworld 2025 Annual Conference the week of December 8, 2025. https://mma.prnewswire.com/media/95729/stag_industrial__inc__logo.jpg In advance of the upcoming conference, the Company has provided a refreshed investor presentation as well as a business update presentation on its website (www.stagindustrial.com) under the “Presentations”

AlphaTime Acquisition Corp and HCYC Holding Company Announce Effectiveness of Registration Statement

(NASDAQ:ATMC),(NASDAQ:ATMCU),(NASDAQ:ATMCW),(NASDAQ:ATMCR), New York, NY, Dec. 04, 2025 (GLOBE NEWSWIRE) — AlphaTime Acquisition Corp (NASDAQ: ATMC) (the “Company” or “AlphaTime”), a special purpose acquisition company, and HCYC Holding Company (“HCYC”), an intermediary insurance brokerage company, today announced the registration statement on Form F-4, as amended (the “Registration Statement”), in connection with the previously announced proposed business

CooperCompanies Announces New Chair of the Board and Strategic Review

(NASDAQ:COO), SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that its Board of Directors has appointed Colleen Jay to succeed current Chair Robert Weiss, effective January 2, 2026. Mr. Weiss will remain on the Board and stand for reelection for the upcoming year, marking

DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights – DXCM

(NASDAQ:DXCM), NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DexCom investors who were adversely affected by alleged securities fraud between January 8, 2024

Scroll to Top